Eventide Gilead Fund
MUTUAL FUND SERIES TRUST · 4 share classes
Fund classification
Classified from what the fund holds · as of 2026 Q2
Eventide Gilead Fund is an actively managed U.S. equity fund. 52% of ETGLX’s stock holdings are in companies whose revenue grew in the top quartile of U.S. companies over the last five fiscal years (covering 89% of the fund’s equity).
- Asset class
- Equity
- Region
- United States
- Management
- Actively managed
- Fund type
- Open-end fund
Fund profile
As filed in the prospectus · 2025 Q4
The Eventide Gilead Fund (the ?Gilead Fund? or the ?Fund?) seeks to provide long-term capital appreciation.
The fund invests primarily in equities across all market capitalizations, both domestic and international, selected through a proprietary faith-based screening process that evaluates companies for integrity, fair treatment of stakeholders, environmental stewardship, and alignment with Christian values including respect for life and freedom from addictive behaviors. The screening methodology also considers financial strength and outlook alongside these values-based criteria. The fund may hold up to 15% in illiquid investments and may use options strategies to generate income or manage risk. Because the fund's eligible investment universe is constrained by faith-based screens rather than broad market representation, its holdings and performance may diverge meaningfully from the overall equity market.
| Share class | Expense ratio |
|---|---|
| ETGLX | 1.38% |
| ETAGX | 1.43% |
| ETCGX | 2.18% |
| ETILX | 1.18% |
Portfolio turnover 60.00% · as of 2025 Q4
Allocation
Asset groups · long / short shown separately, never netted · 2026 Q2
| Stocks | 93.78% |
| Cash & short-term | 4.14% |
| Bonds | 1.04% |
Sector allocation
The same holdings as Allocation above, grouped by market sector instead of asset type · as of 2026 Q2
| Industrials | 27.3% |
| Information Technology | 23.4% |
| Health Care | 22.4% |
| International | 5.9% |
| 7 smaller | 20.9% |
Government, Securitized and Cash are non-corporate buckets; International is foreign holdings we don’t sector-classify, and Other is the residual (held funds, unresolved names).
Portfolio growth profile
How much of the fund’s stock holdings are in fast-growing companies · as of 2026 Q2
Share of the fund’s equity (by value) in companies whose trailing five-year revenue — or net-income — growth ranks in the top 25% of U.S. public companies. Foreign and newly-listed holdings are excluded, so the figure covers only part of the book. From SEC filings — not investment advice. How we measure this.
Latest quarter
What changed since the fund's previous filing
Return profile
Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026
| Share class | 1-year | 3-year | 5-year | Vol | Worst fall |
|---|---|---|---|---|---|
| +35.09% | +46.94% | +8.24% | 17.10% | -18.45% | |
| +34.98% | +46.68% | +8.02% | 17.08% | -18.46% | |
| +34.02% | +43.46% | +4.00% | 17.09% | -18.64% | |
| +35.35% | +47.82% | +9.32% | 17.08% | -18.41% |
These classes hold the same portfolio, so the 5.32pp spread over 5 years is the cost difference between them — roughly 1.06pp a year — not a difference in what they own.
May 2026 and Jun 2026 have been filed since the trailing figures were struck, so they are not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.
Debt profile
What this fund holds — value-weighted across its bond and securitized long positions · as of 2026-06-30
Share of the fund's debt by how its coupon behaves — the fact that decides whether a rate move reaches this portfolio at all.
| Fixed rate | 100.0% |
Share of the fund's debt value in each maturity band, shortest first.
| <1y | 13.9% |
| 1-3y | 58.4% |
| 3-5y | 27.7% |
Based on what filers reported; a filer that never reported a flag also reads as none.
Holdings
By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page
| Ticker | Issuer | %NAV | Reported price | Value | Shares |
|---|---|---|---|---|---|
| LRCX | LAM RESEARCH CORPLRCX | 6.54% | $433.33 | $225.00M | 519.2K |
| XMTR | XOMETRY INCXMTR | 5.88% | $96.52 | $202.26M | 2.1M |
| GH | GUARDANT HEALTH INCGH | 5.52% | $150.03 | $189.83M | 1.3M |
| — | US BANK MMDA | 3.83% | — | $131.61M | — |
| — | ASML HOLDING NV | 3.79% | $1,989.44 | $130.39M | 65.5K |
| TT | TRANE TECHNOLOGIES PLCTT | 2.71% | $491.16 | $93.18M | 189.7K |
| LSCC | LATTICE SEMICONDUCTOR CORPLSCC | 2.61% | $152.96 | $89.73M | 586.6K |
| URI | UNITED RENTALS INCURI | 2.61% | $1,132.89 | $89.71M | 79.2K |
| DDOG | DATADOG INCDDOG | 2.50% | $260.36 | $86.18M | 331.0K |
| GNRC | GENERAC HOLDINGS INCGNRC | 2.49% | $292.81 | $85.60M | 292.4K |
Reported price is the fund's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what the fund paid.
Top 10 positions are 38.47% of net assets, top 25 67.00%, across 73 issuers.
See more of this fund's book
More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.
Sign in free